Publication | Open Access
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
1.1K
Citations
22
References
2016
Year
Gastrointestinal OncologyMedicinePathologyImmune Checkpoint InhibitorGastric CancerCancer TreatmentOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1